The usefulness of pleural fluid presepsin, C-reactive protein, and procalcitonin in distinguishing different causes of pleural effusions
| URI | http://shark.lib.kagawa-u.ac.jp/kuir/metadata/28681 | ||||||
|---|---|---|---|---|---|---|---|
| Title |
The usefulness of pleural fluid presepsin, C-reactive protein, and procalcitonin in distinguishing different causes of pleural effusions
|
||||||
| File |
|
||||||
| Description |
Abstract We aimed to determine the presepsin concentration in pleural fluid from patients with pleural effusions of different aetiologies and to compare its diagnostic value with that of pleural fluid C-reactive protein (CRP) and procalcitonin (PCT). We enrolled 132 patients with pleural effusion who underwent diagnostic evaluation, and we classified them into six categories: empyema, parapneumonic effusion, tuberculous effusion, malignant effusion, paramalignant effusion, and transudate effusion. Additionally, all pleural effusions were categorised as infectious or non-infectious effusions. Receiver operating characteristic analysis was used to evaluate diagnostic performance. When diagnosing empyema, the marker with the highest sensitivity was pleural fluid presepsin (cut-off: 754 pg/mL; sensitivity: 90.9%, specificity: 74.4%) and that with the highest specificity was pleural fluid CRP (cut-off: 4.91 mg/dL; sensitivity: 63.6%, specificity: 89.3%). Pleural fluid PCT tended to be lower in patients with empyema than in those with parapneumonic effusion, but this was not useful for the diagnosis of empyema. When diagnosing infectious pleural effusion, a combination of pleural fluid CRP (cut-off: 2.59 mg/dL) and presepsin (cut-off: 680 pg/mL) produced the highest diagnostic accuracy (83.3%). Pleural fluid presepsin was found at high levels in patients with empyema and parapneumonic effusion. This pattern closely resembles the previously reported pattern of pleural fluid CRP. Some combinations of pleural fluid inflammatory markers may be more clinically useful than these markers in isolation. KEYWORDS: C-reactive protein; Empyema; Pleural effusion; Presepsin; Procalcitonin （医博甲721） |
||||||
| Author |
|
||||||
| Publication Title |
BMC Pulmonary Medicine
|
||||||
| Publication Title Alternative |
BMC Pulm Med.
|
||||||
| Volume |
18
|
||||||
| Issue |
1
|
||||||
| Start Page |
176
|
||||||
| End Page |
176
|
||||||
| Publisher |
BMC (part of Springer Nature)
|
||||||
| Published Date |
2018-11-23
|
||||||
| ISSN |
1471-2466
|
||||||
| NCID |
AA12035438
|
||||||
| PMID |
30470216
|
||||||
| DOI |
10.1186/s12890-018-0740-3
|
||||||
| Resource Type |
Thesis or Dissertation
|
||||||
| Language |
eng
|
||||||
| Relation |
出版社版DOIリンク(URL): https://doi.org/10.1186/s12890-018-0740-3
PMCID: PMC6251181
|
||||||
| Resource URL |
https://doi.org/10.1186/s12890-018-0740-3
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251181/
|
||||||
| Relation(isVersionOf) |
Publisher's Version.
|
||||||
| Rights |
Copyright © The Author(s). 2018
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
DOI: https://doi.org/10.1186/s12890-018-0740-3
|
||||||
| Text Version |
ETD
|
||||||
| Grant ID |
博甲第721号
|
||||||
| Grant Date |
2019-03-24
|
||||||
| Degree Name |
博士（医学）
|
||||||
| Grantor |
香川大学
|
||||||
| Set |
香川大学
|